Literature DB >> 22324956

Detection of anti-nuclear antibody by immunofluorescence assay and enzyme immunoassay in childhood systemic lupus erythematosus: experience from Bangladesh.

Tanjeem Rabika Dipti1, Mohammad Shaiful Azam, Mohammad Humayun Sattar, Shahana Akhter Rahman.   

Abstract

BACKGROUND: Systemic lupus erythematosus (SLE) is a multisystem, chronic but often episodic, autoimmune disease that is characterized by the presence of antinuclear antibodies (ANA). The criteria set by American College of Rheumatology are widely used for diagnosis of SLE. Elevation of ANA titer is the most sensitive of the ACR criteria. There are different methods for detection of ANA. Indirect immunofluorescence (ANA-IFA) and enzyme immunoassay (ANA-EIA) are commonly used methods. The sensitivity of ANA-IFA using HEp-2 cell substrate is 90-100% in systemic rheumatic diseases. In Bangladesh most of the laboratories use ANA-EIA for detection of ANA. As the sensitivity of ANA-EIA is lower than ANA-IFA it might be that we are missing many cases of ANA positivity in childhood SLE cases.
OBJECTIVES: To detect ANA by immunofluorescence assay using HEp-2 cell substrate and enzyme immunoassay in childhood SLE and to compare the diagnostic performance of these methods.
MATERIAL AND METHODS: This is a cross-sectional analytical study. A total of 40 patients were enrolled. Among them 20 were childhood SLE cases. Another 20 patients of childhood rheumatic diseases other than SLE were taken as the disease control group. RESULT: In childhood SLE cases, 100% were ANA-positive by IFA and 55% were ANA positive by EIA. The sensitivity of ANA-IFA was 100%. In contrast, sensitivity of ANA-EIA was 55%.
CONCLUSION: ANA-IFA is superior to ANA-EIA for detection of ANA in childhood SLE patients. ANA-IFA should be the primary screening test for children with clinical features suggestive of SLE.
© 2011 The Authors. International Journal of Rheumatic Diseases © 2011 Asia Pacific League of Associations for Rheumatology and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22324956     DOI: 10.1111/j.1756-185X.2011.01694.x

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  3 in total

1.  Association of calreticulin expression with disease activity and organ damage in systemic lupus erythematosus patients.

Authors:  Yichao Wang; Jiaogui Xie; Zhili Liu; Hongwei Fu; Qianyu Huo; Yajun Gu; Yunde Liu
Journal:  Exp Ther Med       Date:  2017-03-20       Impact factor: 2.447

2.  Antinuclear antibody screening by ELISA and IF techniques: discrepant results in juvenile idiopathic arthritis but consistency in childhood systemic lupus erythematous.

Authors:  Mihaela Spârchez; Dan Delean; Gabriel Samaşcă; Nicolae Miu; Zeno Spârchez
Journal:  Clin Rheumatol       Date:  2014-02-21       Impact factor: 2.980

3.  The prevalence of antinuclear antibodies in the general population of china: a cross-sectional study.

Authors:  Ya-Ping Guo; Chun-Guang Wang; Xin Liu; Yi-Qian Huang; De-Li Guo; Xing-Zhuo Jing; Chun-Gang Yuan; Song Yang; Jin-Mei Liu; Meng-Si Han; Hong-Xing Li
Journal:  Curr Ther Res Clin Exp       Date:  2014-11-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.